A nurse is preparing an in-service for an annual skills fair at a community medical facility about fire safety. Place the steps in the order in which they should be performed in the case of a fire emergency. (Move the steps into the box on the right, placing them in the selected order of performance. Use all the steps.)

A. "Crushing the medication might cause you to have a stomachache or indigestion."
This response provides a potential adverse effect of crushing the medication but does not directly address the reason why the aspirin should not be crushed.
B. "Crushing the medication is a good idea, and I can mix it in some ice cream for you."
This response suggests a solution to the client's difficulty swallowing medication but does not address the safety or efficacy concerns associated with crushing enteric-coated aspirin.
C. "Crushing is unsafe, as it destroys the ingredients in the medication."
While crushing enteric-coated aspirin may alter its release properties, it does not necessarily "destroy" the ingredients. This statement may be too absolute and not entirely accurate.
D. "Crushing the medication would release all the medication at once, rather than over time."
This response accurately explains why enteric-coated aspirin should not be crushed. Enteric coating is designed to prevent dissolution of the medication in the stomach and instead release it in the small intestine to reduce the risk of gastric irritation or ulceration. Crushing the medication would bypass this delayed release mechanism, potentially leading to increased gastric irritation or adverse effects.

A. While heparin and warfarin both work as anticoagulants, IV heparin is not typically used to increase the effects of warfarin or decrease the length of hospital stay. Heparin is often administered initially to rapidly achieve therapeutic anticoagulation while waiting for warfarin to reach its full therapeutic effect, but it is not intended to directly enhance the action of warfarin.
B. This statement is accurate and provides a clear explanation to the client. Warfarin, an oral anticoagulant, takes several days to achieve a therapeutic level in the bloodstream and to exert its anticoagulant effect. During this time, IV heparin is continued to prevent clot formation until the therapeutic level of warfarin is reached.
C. While both heparin and warfarin work to prevent blood clots, they do not directly dissolve existing clots. Rather, they prevent the formation of new clots and the growth of existing ones. This explanation does not fully address the client's question regarding why both medications are necessary.
D. Discontinuing IV heparin prematurely without reaching a therapeutic level of warfarin could increase the risk of thrombus formation or embolization. Therefore, discontinuing IV heparin should be done under the guidance of the provider based on the client's INR levels and the target therapeutic range for warfarin.